Liver transplantation in patients with hepatocellular carcinoma across Milan criteria

J. Ignacio Herrero, Bruno Sangro, Fernando Pardo, Jorge Quiroga, Mercedes Iñarrairaegui, Fernando Rotellar, Custodia Montiel, Felix Alegre, Jesus Prieto – 27 February 2008 – Milan criteria are the most frequently used limits for liver transplantation (LT) in patients with hepatocellular carcinoma (HCC), but our previous experience with expanded criteria showed encouraging results. The aim of this study was to investigate whether our expanded Clinica Universitaria de Navarra (CUN) criteria (1 nodule up to 6 cm or 2–3 nodules up to 5 cm each) could be used to select patients with HCC for LT.

Long‐term, tumor‐free survival after radiotherapy combining hepatectomy‐Whipple en bloc and orthotopic liver transplantation for early‐stage hilar cholangiocarcinoma

Youmin Wu, Frederick C. Johlin, Stephen C. Rayhill, Chris S. Jensen, Jin Xie, Michael B. Cohen, Frank A. Mitros – 27 February 2008 – This retrospective study reviews our experience in surveillance and early detection of cholangiocarcinoma (CC) and in using en bloc total hepatectomy–pancreaticoduodenectomy–orthotopic liver transplantation (OLT‐Whipple) to achieve complete eradication of early‐stage CC complicating primary sclerosing cholangitis (PSC).

Cure of Acanthamoeba cerebral abscess in a liver transplant patient

Konrad Tang‐Tat Fung, Amar Paul Dhillon, James E. McLaughlin, Sebastian B. Lucas, Brian Davidson, Keith Rolles, David Patch, Andrew K. Burroughs – 27 February 2008 – Acanthamoeba‐related cerebral abscess and encephalitis are rare but usually fatal, being caused by free‐living amoebic infections usually occurring in immunocompromised patients. In patients receiving transplants, a literature review showed that the infection is universally fatal. The diagnosis is often missed despite appropriate investigations including lumbar puncture, computerized tomography, and brain biopsy.

Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation

Antonia D'Errico‐Grigioni, Michelangelo Fiorentino, Francesco Vasuri, Elisa Gruppioni, Benedetta Fabbrizio, Nicola Zucchini, Giorgio Ballardini, Cristina Morelli, Antonio Daniele Pinna, Walter Franco Grigioni – 27 February 2008 – We compared tissue hepatitis C virus (HCV) RNA polymerase chain reaction quantification and HCV immunohistochemistry (IHC) to histology in biopsy tissues in order to differentiate between acute rejection and HCV hepatitis recurrence early after orthotopic liver transplantation (OLT).

Retrograde oxygen persufflation preservation of human livers: A pilot study

Jürgen Treckmann, Thomas Minor, Stefano Saad, Arzu Özcelik, Massimo Malagó, Christoph Erich Broelsch, Andreas Paul – 27 February 2008 – Retrograde oxygen persufflation as a supplement of cold storage during the preservation period has the potential to better utilize ischemically damaged marginal livers in the experimental setting. Retrograde oxygen persufflation was applied in selected livers to demonstrate feasibility in the clinical setting and to investigate potential beneficial effects.

Isolation and functional identification of a novel human hepatic growth factor: Hepatopoietin Cn

Chun‐Ping Cui, Da‐Jin Zhang, Bing‐Xing Shi, Shao‐Jun Du, Dan‐Li Wu, Ping Wei, Gen‐Shen Zhong, Zi‐Kuan Guo, Yang Liu, Li‐Sheng Wang, Chu‐Tse Wu – 27 February 2008 – Hepatic stimulating substance (HSS) was first isolated from weanling rat liver in 1975 and found to stimulate hepatic DNA synthesis both in vitro and in vivo. Since then, mammalian and human HSS have been investigated for their potential to treat hepatic diseases. However, the essential nature in composition and structure of HSS remain puzzling because HSS has not been completely purified.

Subscribe to